LEADER 04413nam 22006615 450 001 9910300183903321 005 20200703201303.0 010 $a3-662-44000-8 024 7 $a10.1007/978-3-662-44000-1 035 $a(CKB)3710000000315952 035 $a(EBL)1966095 035 $a(OCoLC)908085091 035 $a(SSID)ssj0001408275 035 $a(PQKBManifestationID)11727564 035 $a(PQKBTitleCode)TC0001408275 035 $a(PQKBWorkID)11346331 035 $a(PQKB)10223463 035 $a(DE-He213)978-3-662-44000-1 035 $a(MiAaPQ)EBC1966095 035 $a(PPN)183148037 035 $a(EXLCZ)993710000000315952 100 $a20141213d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aInfections in Hematology /$fedited by Georg Maschmeyer, Kenneth V.I. Rolston 205 $a1st ed. 2015. 210 1$aBerlin, Heidelberg :$cSpringer Berlin Heidelberg :$cImprint: Springer,$d2015. 215 $a1 online resource (328 p.) 300 $aDescription based upon print version of record. 311 $a3-662-43999-9 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aInfections in Patients with Acute Leukemia -- Infections in Patients with Malignant Lymphomas -- Consequences from specific treatment modalities -- Infections after high-dose chemotherapy and autologous hematopoietic stem cell transplantation -- Microbiological Background -- The Diagnostic Approach to the Febrile Neutropenic Patient: Clinical Considerations -- Diagnostic Radiology in Hematological Patients with Febrile Neutropenia -- Risk Stratification in Febrile Neutropenic Patients -- Fever of Unknown Origin: Treatment According to Risk Assessment -- Pulmonary Complications -- Vascular Catheter-Related Infections -- Gastrointestinal Complications -- Central Nervous System Infections -- Antibacterial Agents -- Antifungal Agents -- Antimicrobial Prophylaxis in Hematology -- Infection Control and Hospital Epidemiology in Hematology Units -- Myeloid Growth Factors. 330 $aInfections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation. A profound knowledge on the epidemiology, diagnostic approaches, treatment modalities, and prophylactic strategies is essential for the clinical management of these complications in patients who are often severely immunocompromised owing to their underlying diseases and, in particular, the intensive myelosuppressive chemo- and immunotherapy.  This textbook provides a clinically oriented, compact, and up-to-date overview on infections in hematology patients and their management. The typical pathogens to be considered in different subgroups of patients are identified, and further aspects of the microbiological background are explored. Clinical, imaging, and laboratory-based diagnostic techniques are discussed, and therapeutic strategies appropriate to different situations are then presented, with due attention to the pitfalls, toxicities, and interactions that can arise during antimicrobial treatment. Strategies to prevent infection are also outlined, encompassing antimicrobial prophylaxis, isolation procedures, hospital hygiene, protective immunization, and the use of hematopoietic growth factors. 606 $aHematology 606 $aOncology   606 $aSurgical transplantation 606 $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aTransplant Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59117 615 0$aHematology. 615 0$aOncology  . 615 0$aSurgical transplantation. 615 14$aHematology. 615 24$aOncology. 615 24$aTransplant Surgery. 676 $a610 676 $a616.15 676 $a616994 676 $a617954 702 $aMaschmeyer$b Georg$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aRolston$b Kenneth V.I$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300183903321 996 $aInfections in Hematology$91866571 997 $aUNINA